These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12211350)

  • 1. Cochlear function in ears with immunomediated inner ear disorder.
    Quaranta A; Scaringi A; Sallustio V; Quaranta N
    Acta Otolaryngol Suppl; 2002; (548):15-9. PubMed ID: 12211350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Audiological test results of the autoimmune sensorineural hearing loss].
    Gu R; Zou J; Yu L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(1):20-3. PubMed ID: 7598979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transiently evoked otoacoustic emissions in patients with cerebellopontine angle tumors.
    Cane MA; Lutman ME; O'Donoghue GM
    Am J Otol; 1994 Mar; 15(2):207-16. PubMed ID: 8172303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Auto-immune sensorineural deafness: physiopathology and therapeutic approach].
    Hervier B; Bordure P; Masseau A; Calais C; Agard C; Hamidou M
    Rev Med Interne; 2010 Mar; 31(3):222-8. PubMed ID: 19233519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated hearing loss: basic mechanisms and options for therapy.
    Ryan AF; Harris JP; Keithley EM
    Acta Otolaryngol Suppl; 2002; (548):38-43. PubMed ID: 12211356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Sensorineural Hearing Loss Using Various Transient-Evoked Otoacoustic Emission Stimulus Conditions.
    Putterman DB; Keefe DH; Hunter LL; Garinis AC; Fitzpatrick DF; McMillan GP; Feeney MP
    Ear Hear; 2017; 38(4):507-520. PubMed ID: 28437273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion product otoacoustic emission test of sensorineural hearing loss: performance regarding sensitivity, specificity and receiver operating characteristics.
    Kim DO; Paparello J; Jung MD; Smurzynski J; Sun X
    Acta Otolaryngol; 1996 Jan; 116(1):3-11. PubMed ID: 8820343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distortion product otoacoustic emissions in sensorineural hearing loss].
    Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 1999; 53(6):693-8. PubMed ID: 10763321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion product otoacoustic emissions for hearing threshold estimation and differentiation between middle-ear and cochlear disorders in neonates.
    Janssen T; Gehr DD; Klein A; Müller J
    J Acoust Soc Am; 2005 May; 117(5):2969-79. PubMed ID: 15957767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Otoacoustic emission and auditory efferent function testing in normal subjects and patients with sensori-neural hearing loss].
    Liang F; Liu C; Liu B
    Zhonghua Yi Xue Za Zhi; 1996 Oct; 76(10):763-6. PubMed ID: 9275520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of evoked otoacoustic emissions associated with acoustic neuromas.
    Telischi FF; Roth J; Stagner BB; Lonsbury-Martin BL; Balkany TJ
    Laryngoscope; 1995 Jul; 105(7 Pt 1):675-82. PubMed ID: 7603269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of positron emission tomography in the evaluation of autoimmune hearing loss.
    Mazlumzadeh M; Lowe VJ; Mullan BP; Fabry DA; McDonald TJ; Matteson EL
    Otol Neurotol; 2003 Mar; 24(2):201-4. PubMed ID: 12621332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lifetime noise exposure on the middle-age human auditory brainstem response, tinnitus and speech-in-noise intelligibility.
    Valderrama JT; Beach EF; Yeend I; Sharma M; Van Dun B; Dillon H
    Hear Res; 2018 Aug; 365():36-48. PubMed ID: 29913342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acoustic distortion product recording in patients with sensorineural hearing loss].
    Pérez del Valle B; Morant Ventura A; Contreras Castelló A; Orts Albors M; Marco Algarra J
    Acta Otorrinolaringol Esp; 1996; 47(2):111-8. PubMed ID: 8695198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical dysfunction of cochlea and cochlear efferents in migraine: an otoacoustic emission study.
    Bolay H; Bayazit YA; Gündüz B; Ugur AK; Akçali D; Altunyay S; Ilica S; Babacan A
    Cephalalgia; 2008 Apr; 28(4):309-17. PubMed ID: 18279433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote masking, brief tone audiometry and critical ratio in sensorineural hearing losses.
    Quaranta A; Salonna I; Longo G
    Scand Audiol Suppl; 1986; 25():153-8. PubMed ID: 3472319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
    Kagoya R; Shinogami M; Kohno M; Yamasoba T
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.